MingMed Biotech

Guangzhou, China · Founded 2019 · Privately Held (backing)

Developer of pharmaceutical drugs intended for global pharmaceutical markets and healthcare providers. MingMed Biotech is based in Guangzhou, China and was founded in 2019. Its last reported valuation was $615 million in Jul 2022. It has raised $140 million.

Last reported valuation
$615.4M
Oct 2026
Priced at
—
Total raised
$139.8M
Last round
—

Who backs MingMed Biotech?

16 investors
InvestorType
CAS StarOther
Shenzhen Yifeng Investment Management EnterpriseVenture capital
Oceanpine CapitalGrowth equity
Hengqin Financial InvestmentOther
Taiping Life Insurance CompanyOther
Beyond Ventures—
Chengxin VC—
Gaorong Ventures—
Guangzhou Huacheng Venture Capital Management—
JCP Capital—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MingMed Biotech investors

16 investors are on record for MingMed Biotech, including CAS Star, Shenzhen Yifeng Investment Management Enterprise, Oceanpine Capital and Hengqin Financial Investment.

Free account
More of MingMed Biotech with a free account
  • ·The complete investor list: 16 names
  • ·Watch MingMed Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like MingMed Biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View